Research

Project

Cost-Effectiveness analysis of 3 months of weekly refapetine and isoniazid for treatment of latent tuberculosis in South Korea

January 2021 - Present
  • Developed age-structured tuberculosis (TB) model
  • Calibrated the model to fit yearly TB incidence data using least-squares estimation (LSE)
  • Collaborated with Yunjeong Lee and Hye Seong

Cost-benefit analysis of tafenoquine for radical cure of Plasmodium vivax malaria in South Korea

October 2020 - Present
  • Expanded P. vivax malaria model to decribe relapse incidences in detail
  • Calibrated the model to fit weekly malaria incidence data using maximum likelihood method (MLE)
  • Predicted future malaria incidences and performed cost-benefit analysis (CBA) of tafenoquine
  • Conducted probabilistic sensitivity analysis (PSA)
  • Collaborated with Jung Ho Kim and Joon-Sup Yeom

Development of agent-based model for malaria to predict the time for elimination in South Korea

August 2020 - Present
  • Developed agent-based model (ABM) for P. vivax malaria
  • Analyzed epidemiological data by region, age and sex in the malaria risk-area
  • Collaborated with Chansoo Kim, Jung Ho Kim, and Joon-Sup Yeom

Analysis of differential equations with multiple delays and seasonality for malaria

April 2020 - Present
  • Showed well-posedness of the multiple delay differential equations (DDEs), Cauchy problem
  • Calculated basic reproduction number in the multiple DDE malaria model
  • Analyzed steady states: disease-free and endemic equilibriums, Wazewski system, Sevastyanov-Kotelyanskii criterion
  • Performed numerical simulations for stability analysis
  • Collaborated with Hee-Dae Kwon

Evaluation of the impact of rapid diagnostic test and tafenoquine on the burden of malaria in North Korea

December 2019 - Present
  • Developed P. vivax malaria model in North Korea
  • Calibrated the model to fit yearly malaria incidence data using LSE
  • Predicted future malaria incidences under rapid diagnostic test (RDT) and tafenoquine scenarios and performed sensitivity analysis
  • Collaborated with Hye Seong and Joon-Sup Yeom

Cost-effectiveness analysis of herpes zoster vaccination in South Korea

October 2019 - Present
  • Expanded varicella zoster virus (VZV) model from the previous study
  • Estimate the effect of herpes zoster (HZ) vaccination on the varicella and HZ incidences
  • Performed cost-effectiveness analysis based on HIRA data
  • Collaborated with Sun Hee Park

Estimation of varicella vaccine effectiveness from varicella incidence data in South Korea

September 2019 - Present
  • Estimated varicella vaccine effectiveness under 1-dose and 2-dose strategies
  • Estimated parameters using LSE, MLE and confidence intervals using profile likelihood, bootstrapping
  • Collaborated with Sun Hee Park

Cost-benefit analysis of rapid diagnostic test for malaria in South Korea

April 2019 - October 2020
  • Developed P. vivax malaria model in South Korea using DDEs and incorporating seasonality
  • Calibrated the model to fit weekly malaria incidence data using LSE
  • Predicted future malaria incidences performed cost-benefit analysis of RDT and PSA
  • Collaborated with Jung Ho Kim and Joon-sup Yeom

Estimation of the impact of 2-dose varicella vaccination on varicella and herpes zoster epidemiology in South Korea

July 2018 - December 2020
  • Developed age stratified VZV model incorporating dynamic population structure
  • Assessed the impact of 2-dose varicella vaccinations on the disease burden
  • Estimated optimal 2nd dose timing
  • Performed sensitivity analysis including WAIFW (Who Acquires Infection From Whom) matrix
  • Collaborated with Sun Hee Park

Development of mixed-effects model for in-host HIV model using hierarchical Bayesian approach

May 2018 - July 2019
  • Developed mixed-effects model based on the in-host HIV model
  • Estimated individual and population level parameters using MCMC method

Cost-effectiveness of pre-exposure prophylaxis in men who have sex with men in South Korea

March 2017 - August 2018
  • Developed population level HIV model
  • Predicted HIV incidence among general and high-risk MSM
  • Estimated incremental cost-effectiveness ratio (ICER) of pre-exposure prophylaxis (PrEP)
  • Performed sensitivity analysis of ICER
  • Collaborated with Heun Choi and Jun Yong Choi

Development of numerical algorithms for molecular diagnostic tools in Seegene

August 2015 - September 2015
  • Developed numerical algorithm to determine the baseline threshold in real-time PCR
  • Developed numerical algorithm to discriminate two targets in one channel in MuDTTM technology
  • Collaborated with Seegene